The Ethics of Weaponized Intelligence: Dark Patterns in CI
a) Navigating Grey Areas: The life sciences industry sits at the intersection of innovation and regulation. While CI is vital, how do we draw the line between valuable insights and unethical practices, such as scraping conference data? i.e., how often are we contacted by companies claiming to have this type of data? How far is too far?
b) The Social Media Dilemma: Monitoring competitors’ social media can offer critical insights, but it also raises questions about privacy and ethics. Where should we draw the line?
c) Avoiding the Espionage Trap: CI in a heavily regulated sector can veer into dangerous territory if not handled with care. How can organizations ensure that their CI efforts remain on the right side of the law and ethics? Given the musical chair within the industry, at times “secret sauce” might be share unintentionally.
d) Creating Ethical CI Frameworks: The key is to develop a transparent yet impactful CI strategy that provides actionable insights while maintaining high ethical standards.

Presented by Qiagen